Should Relaxed Methadone Rules Continue After the Pandemic Ends?
The authors propose evaluating which aspects of previous policy and practices for OUD should resume and which aspects of current policy and practice exemptions should continue.
The authors propose evaluating which aspects of previous policy and practices for OUD should resume and which aspects of current policy and practice exemptions should continue.
Opioid products approved by the FDA between 1997 and 2018 relied on short- or intermediate-term studies that did not adequately analyze safety outcomes.
Growth parameters similar to those for newborns of women with opioid use disorders during pregnancy
Curtailing prescription opioid use has led to an increase in prescribing benzodiazepines to manage pain.
Numbers and rates increased for all sex, age, racial and ethnic subgroups, most public health regions
Treating osteoarthritis in older patients with tramadol vs nonsteroidal anti-inflammatory drugs may be associated with an increased mortality rate during the year following treatment initiation.
Generic versions of Suboxone (buprenorphine and naloxone; Indivior) Sublingual Film have been made available by Sandoz and Alvogen.
Sandoz and Pear Therapeutics announced the launch of reSET-O, a new digital therapeutic for patients aged ≥18 years with opioid use disorder (OUD) currently under clinician care.
Recommendations from the American Gastroenterological Association (AGA) for the medical management of opioid-induced constipation (OIC).
The labels of prescription opioid painkillers should advise doctors to consider simultaneously prescribing the opioid overdose antidote naloxone, 2 US Food and Drug Administration advisory panels recommend.